abstract |
This application belongs to the field of biological immunity technology, and specifically relates to monoclonal antibodies and antigen-binding fragments thereof that can specifically bind to human carcinoembryonic antigen cell adhesion molecule 5 (CEACAM5). This application also relates to methods for preparing the antibodies and antigen-binding fragments thereof And uses. |